ATE275971T1 - Sonodynamische therapie mit ultraschalsensibilisator - Google Patents

Sonodynamische therapie mit ultraschalsensibilisator

Info

Publication number
ATE275971T1
ATE275971T1 AT98921658T AT98921658T ATE275971T1 AT E275971 T1 ATE275971 T1 AT E275971T1 AT 98921658 T AT98921658 T AT 98921658T AT 98921658 T AT98921658 T AT 98921658T AT E275971 T1 ATE275971 T1 AT E275971T1
Authority
AT
Austria
Prior art keywords
sensitizer
sonodynamic therapy
ultrasheet
sensitizer agent
cytopathogenic
Prior art date
Application number
AT98921658T
Other languages
English (en)
Inventor
Jan Alan Alfheim
Paul Mark Henrichs
Eric Paul Hohenschuh
Edvin Wilhelm Johannesen
William Anthony Sanderson
Robert Allen Snow
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE275971T1 publication Critical patent/ATE275971T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Semiconductor Lasers (AREA)
AT98921658T 1997-05-19 1998-05-19 Sonodynamische therapie mit ultraschalsensibilisator ATE275971T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710049.9A GB9710049D0 (en) 1997-05-19 1997-05-19 Method
PCT/GB1998/001444 WO1998052609A1 (en) 1997-05-19 1998-05-19 Sonodynamic therapy using an ultrasound sensitizer compound

Publications (1)

Publication Number Publication Date
ATE275971T1 true ATE275971T1 (de) 2004-10-15

Family

ID=10812481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921658T ATE275971T1 (de) 1997-05-19 1998-05-19 Sonodynamische therapie mit ultraschalsensibilisator

Country Status (8)

Country Link
US (1) US6498945B1 (de)
EP (1) EP0979104B1 (de)
JP (1) JP4503103B2 (de)
AT (1) ATE275971T1 (de)
AU (1) AU7443898A (de)
DE (1) DE69826263T2 (de)
GB (1) GB9710049D0 (de)
WO (1) WO1998052609A1 (de)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593148B1 (en) * 1994-03-01 2003-07-15 Li-Cor, Inc. Cyanine dye compounds and labeling methods
JPH10279502A (ja) * 1997-03-31 1998-10-20 Katsuro Tachibana 光感受性物質の励起方法
EP1082138B1 (de) * 1998-06-05 2004-08-25 The Board Of Regents, The University Of Texas System Texaphyrin-konjugate und ihre anwendiung
CA2335808A1 (en) * 1998-07-06 2000-01-13 David Kessel Intracellular sensitizers for sonodynamic therapy
US20030180221A1 (en) * 1998-09-18 2003-09-25 Schering Ag Near infrared fluorescent contrast agent and fluorescence imaging
US7547721B1 (en) 1998-09-18 2009-06-16 Bayer Schering Pharma Ag Near infrared fluorescent contrast agent and fluorescence imaging
JP2000095758A (ja) 1998-09-18 2000-04-04 Schering Ag 近赤外蛍光造影剤および蛍光造影方法
DE60026313D1 (de) 1999-07-23 2006-04-27 Uutech Ltd Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes
US20050182434A1 (en) * 2000-08-11 2005-08-18 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US6915154B1 (en) * 1999-09-24 2005-07-05 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
DE10016559A1 (de) * 2000-04-03 2001-10-18 Eucro Europe Contract Res Gmbh System für den Transport von Aktivstoffen in einem biologischen System
US7597878B2 (en) * 2000-09-19 2009-10-06 Li-Cor, Inc. Optical fluorescent imaging
EP1319047B1 (de) 2000-09-19 2006-01-04 Li-Cor, Inc. Cyaninfarbstoffe
US7003345B1 (en) * 2000-10-17 2006-02-21 Lucid, Inc. System and method for enhancing microscope images of tissue using citric acid and agents of the like
US7139122B1 (en) 2000-10-17 2006-11-21 Lucid, Inc. System and method for enhancing confocal reflectance images of tissue specimens
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
EP1357944B1 (de) * 2001-01-30 2007-06-13 Altachem Pharma Ltd. Perylenequinone zur anwendung mit immunotherapeutischen mitteln
US6884797B2 (en) * 2001-03-30 2005-04-26 Robert F. Hofmann Targeted oxidative therapeutic formulation
US20030109824A1 (en) * 2001-11-07 2003-06-12 Microvena Corporation Distal protection device with local drug delivery to maintain patency
DE60210254D1 (de) * 2002-01-29 2006-05-18 Altachem Pharma Ltd Aminosubstituierter hypocrelline zur verwendung als sonosensitizer
US20040133112A1 (en) * 2002-03-08 2004-07-08 Milind Rajadhyaksha System and method for macroscopic and confocal imaging of tissue
EP1517684B1 (de) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
DE60323766D1 (de) * 2003-01-24 2008-11-06 Bayer Schering Pharma Ag En konjugate mit biomolekülen für fluoreszenzdiagnose
US7175089B2 (en) * 2003-04-07 2007-02-13 Silverbrook Research Pty Ltd Face determination
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US8986731B2 (en) * 2003-08-26 2015-03-24 Biolitec Pharma Marketing Ltd Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
US20080119421A1 (en) * 2003-10-31 2008-05-22 Jack Tuszynski Process for treating a biological organism
US20050095197A1 (en) * 2003-10-31 2005-05-05 Tuszynski Jack A. Anti-mitotic compound
US7662114B2 (en) * 2004-03-02 2010-02-16 Focus Surgery, Inc. Ultrasound phased arrays
WO2006104510A2 (en) * 2004-08-20 2006-10-05 Technology Innovations, Llc Water-soluble compound
AU2005295261A1 (en) * 2004-10-19 2006-04-27 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health Methods and compositions for protecting cells from ultrasound-mediated cytolysis
US20060239921A1 (en) 2005-04-26 2006-10-26 Novadaq Technologies Inc. Real time vascular imaging during solid organ transplant
WO2008048205A2 (en) * 2005-06-20 2008-04-24 The Research Foundation Of State University Of New York Stor Intellectual Property Division Method for delivering hydrophobic drugs via nanocrystal formulations
US7720267B2 (en) * 2005-07-15 2010-05-18 Siemens Medical Solutions Usa, Inc. Method and apparatus for classifying tissue using image data
WO2007016762A1 (en) 2005-08-10 2007-02-15 Quest Pharmatech Inc. Perylenequinone derivatives and uses thereof
WO2007025244A2 (en) 2005-08-25 2007-03-01 Houle Philip R Treatment systems for delivery of sensitizer solutions
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
US20070154538A1 (en) * 2005-12-29 2007-07-05 Ceramoptec Gmbh Removal of fat cells by PDT
US20070208331A1 (en) * 2006-03-02 2007-09-06 Chu Michael S Systems and methods of treatment within a gastrointestinal lumen
US8454991B2 (en) 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN101500649A (zh) * 2006-08-09 2009-08-05 皇家飞利浦电子股份有限公司 胶囊以及利用超声波激活生理有效物质的设备和方法
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US20100041989A1 (en) * 2006-09-29 2010-02-18 The Trustees Of The University Of Pennsylvania Use of ultrasound as an antivascular agent
DE102006054523B4 (de) * 2006-11-20 2009-07-23 Novaled Ag Dithiolenübergangsmetallkomplexe und Selen-analoge Verbindungen, deren Verwendung als Dotand, organisches halbleitendes Material enthaltend die Komplexe, sowie elektronische oder optoelektronisches Bauelement enthaltend einen Komplex
WO2008067445A2 (en) * 2006-11-29 2008-06-05 Sun Chemical Corporation Poly(oxyalkylene)ated colorants and their use as fluorescent security taggants
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
EP2036577A1 (de) * 2007-09-14 2009-03-18 mivenion GmbH Diagnostische Stoffe für die optische bildgebende Untersuchung auf der Basis von nanopartikulären Formulierungen
JP5643101B2 (ja) 2007-10-25 2014-12-17 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 散乱媒体の画像化方法、画像化装置及び画像化システム
WO2009065065A1 (en) * 2007-11-15 2009-05-22 Ceramoptec Industries, Inc. Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
US9040079B2 (en) * 2007-11-19 2015-05-26 Biolitec Pharma Marketing Ltd Pegylated compounds for age-related macular degeneration
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
EP2687235A3 (de) 2008-05-02 2014-11-05 Novadaq Technologies Inc. Verfahren zur Herstellung und Verwendung substanzbeladener Erythrozyten (S-LES) zur Beobachtung und Behandlung von mikrovaskulärer Hämodynamik
GB0820309D0 (en) * 2008-11-06 2008-12-17 Middlesex University Higher Ed Detection of cancer
US9351705B2 (en) 2009-01-09 2016-05-31 Washington University Miniaturized photoacoustic imaging apparatus including a rotatable reflector
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
WO2011127428A2 (en) 2010-04-09 2011-10-13 Washington University Quantification of optical absorption coefficients using acoustic spectra in photoacoustic tomography
US8997572B2 (en) 2011-02-11 2015-04-07 Washington University Multi-focus optical-resolution photoacoustic microscopy with ultrasonic array detection
US9138492B2 (en) 2012-02-23 2015-09-22 Canon Kabushiki Kaisha Particle containing hydrophobic dye having cyanine structure, and contrast agent containing the particle
US8974830B2 (en) 2012-02-23 2015-03-10 Canon Kabushiki Kaisha Particles and contrast agent including the same for optical imaging
WO2013181738A1 (en) 2012-06-04 2013-12-12 Suncor Energy Inc. Formulations containing paraffinic oil and anti-settling agent
JP6028096B2 (ja) 2012-06-21 2016-11-16 ノバダック テクノロジーズ インコーポレイテッド 血管造影及びかん流の定量化並びに解析手法
KR102530118B1 (ko) 2012-07-25 2023-05-08 더 브로드 인스티튜트, 인코퍼레이티드 유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
US11020006B2 (en) 2012-10-18 2021-06-01 California Institute Of Technology Transcranial photoacoustic/thermoacoustic tomography brain imaging informed by adjunct image data
EP2967056B1 (de) 2013-03-15 2018-02-21 Suncor Energy Inc. Herbizidzusammensetzungen
WO2015077355A1 (en) 2013-11-19 2015-05-28 Washington University Systems and methods of grueneisen-relaxation photoacoustic microscopy and photoacoustic wavefront shaping
CN107209118B (zh) 2014-09-29 2021-05-28 史赛克欧洲运营有限公司 在自体荧光存在下生物材料中目标荧光团的成像
KR102012880B1 (ko) 2014-10-09 2019-08-22 노바다크 테크놀러지즈 유엘씨 형광-조정 광전용적맥파 측정기를 사용한 조직 내의 절대적인 혈류의 정량화
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
TWI813532B (zh) 2015-06-18 2023-09-01 美商博得學院股份有限公司 降低脱靶效應的ｃｒｉｓｐｒ酶突變
WO2017106657A1 (en) 2015-12-18 2017-06-22 The Broad Institute Inc. Novel crispr enzymes and systems
US20200263190A1 (en) 2016-04-19 2020-08-20 The Broad Institute, Inc. Novel crispr enzymes and systems
EP3445853A1 (de) 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1-komplexe mit reduzierter indelaktivität
CN110382692A (zh) 2016-04-19 2019-10-25 博德研究所 新型crispr酶以及系统
US12595478B2 (en) 2016-06-29 2026-04-07 The Broad Institute, Inc. Crispr-Cas systems having destabilization domain
EP4242743A3 (de) 2017-02-10 2023-10-18 Stryker European Operations Limited Handhaltbare offenfeld-fluoreszenzbildgebungssysteme und verfahren
US12161694B2 (en) 2017-03-24 2024-12-10 The Broad Institute, Inc. Methods and compositions for regulating innate lymphoid cell inflammatory responses
WO2018183908A1 (en) 2017-03-31 2018-10-04 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating ovarian tumors
WO2018191558A1 (en) 2017-04-12 2018-10-18 The Broad Institute, Inc. Modulation of epithelial cell differentiation, maintenance and/or function through t cell action, and markers and methods of use thereof
US20200071773A1 (en) 2017-04-12 2020-03-05 Massachusetts Eye And Ear Infirmary Tumor signature for metastasis, compositions of matter methods of use thereof
US11672426B2 (en) 2017-05-10 2023-06-13 California Institute Of Technology Snapshot photoacoustic photography using an ergodic relay
EP3622092A4 (de) 2017-05-11 2021-06-23 The Broad Institute, Inc. Verfahren und zusammensetzungen zur verwendung von cd8+-tumor-infiltrierenden lymphozyten-subtypen und gensignaturen davon
EP3625342B1 (de) 2017-05-18 2022-08-24 The Broad Institute, Inc. Systeme, verfahren und zusammensetzungen zur gezielten nukleinsäureeditierung
GB201708663D0 (en) * 2017-05-31 2017-07-12 Univ Ulster Therapy
WO2018232195A1 (en) 2017-06-14 2018-12-20 The Broad Institute, Inc. Compositions and methods targeting complement component 3 for inhibiting tumor growth
AU2018290843B2 (en) 2017-06-26 2025-04-24 Massachusetts Institute Of Technology CRISPR/Cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
US12049643B2 (en) 2017-07-14 2024-07-30 The Broad Institute, Inc. Methods and compositions for modulating cytotoxic lymphocyte activity
EP3654993A4 (de) 2017-07-17 2021-08-25 The Broad Institute, Inc. Zellatlas des gesunden menschlichen dickdarms und menschlichen dickdarms mit colitis ulcerosa
WO2019050963A1 (en) * 2017-09-05 2019-03-14 University Of Pittsburgh -Of The Commonwealth System Of Higher Education SONODYNAMIC THERAPY USING MICROBULLES AND METHODS AND SYSTEMS ULTRASOUNDED WITH PULSED WAVES
JP2020535802A (ja) 2017-09-21 2020-12-10 ザ・ブロード・インスティテュート・インコーポレイテッド 標的化核酸編集のための系、方法、及び組成物
EP3692152B1 (de) 2017-10-04 2025-09-03 The Broad Institute, Inc. Verfahren und zusammensetzungen zur veränderung der funktion und struktur von chromatinschleifen und/oder -domänen
US12227742B2 (en) 2017-10-23 2025-02-18 The Broad Institute, Inc. Nucleic acid modifiers
WO2019094984A1 (en) 2017-11-13 2019-05-16 The Broad Institute, Inc. Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells
WO2019094955A1 (en) 2017-11-13 2019-05-16 The Broad Institute, Inc. Methods and compositions for targeting developmental and oncogenic programs in h3k27m gliomas
EP3710039A4 (de) 2017-11-13 2021-08-04 The Broad Institute, Inc. Verfahren und zusammensetzungen zur behandlung von krebs durch targeting des clec2d-klrb1-wegs
WO2019113506A1 (en) 2017-12-07 2019-06-13 The Broad Institute, Inc. Methods and compositions for multiplexing single cell and single nuclei sequencing
WO2019126709A1 (en) 2017-12-22 2019-06-27 The Broad Institute, Inc. Cas12b systems, methods, and compositions for targeted dna base editing
CN111712468A (zh) 2017-12-22 2020-09-25 北卡罗莱纳州立大学 聚合物荧光团、包含其的组合物及制备和使用其的方法
US11994512B2 (en) 2018-01-04 2024-05-28 Massachusetts Institute Of Technology Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity
US11957695B2 (en) 2018-04-26 2024-04-16 The Broad Institute, Inc. Methods and compositions targeting glucocorticoid signaling for modulating immune responses
WO2019210268A2 (en) 2018-04-27 2019-10-31 The Broad Institute, Inc. Sequencing-based proteomics
US20210371932A1 (en) 2018-06-01 2021-12-02 Massachusetts Institute Of Technology Methods and compositions for detecting and modulating microenvironment gene signatures from the csf of metastasis patients
US12036240B2 (en) 2018-06-14 2024-07-16 The Broad Institute, Inc. Compositions and methods targeting complement component 3 for inhibiting tumor growth
CN113286884A (zh) 2018-08-07 2021-08-20 博德研究所 新型cas12b酶和系统
US11530979B2 (en) 2018-08-14 2022-12-20 California Institute Of Technology Multifocal photoacoustic microscopy through an ergodic relay
US12460244B2 (en) 2018-08-20 2025-11-04 The Broad Institute, Inc. Inhibitors of RNA-guided nuclease activity and uses thereof
US20210324357A1 (en) 2018-08-20 2021-10-21 The Brigham And Women's Hospital, Inc. Degradation domain modifications for spatio-temporal control of rna-guided nucleases
WO2020041380A1 (en) 2018-08-20 2020-02-27 The Broad Institute, Inc. Methods and compositions for optochemical control of crispr-cas9
WO2020051246A1 (en) 2018-09-04 2020-03-12 California Institute Of Technology Enhanced-resolution infrared photoacoustic microscopy and spectroscopy
JP7344300B2 (ja) 2018-09-18 2023-09-13 ブイエヌブイ ニューコ インク． Ａｒｃベースのカプシドおよびその使用
US20220401460A1 (en) 2018-10-10 2022-12-22 Dana-Farber Cancer Institute, Inc. Modulating resistance to bcl-2 inhibitors
US20220411783A1 (en) 2018-10-12 2022-12-29 The Broad Institute, Inc. Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
US20210379057A1 (en) 2018-10-16 2021-12-09 Massachusetts Institute Of Technology Nutlin-3a for use in treating a mycobacterium tuberculosis infection
US12402610B2 (en) 2018-11-09 2025-09-02 The Broad Institute, Inc. Methods and compositions for modulating innate lymphoid cell pathogenic effectors
US12165743B2 (en) 2018-11-09 2024-12-10 The Broad Institute, Inc. Compressed sensing for screening and tissue imaging
WO2020102610A1 (en) 2018-11-14 2020-05-22 The Broad Institute, Inc. Crispr system based droplet diagnostic systems and methods
WO2020124050A1 (en) 2018-12-13 2020-06-18 The Broad Institute, Inc. Tiled assays using crispr-cas based detection
CA3124110A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
US11739156B2 (en) 2019-01-06 2023-08-29 The Broad Institute, Inc. Massachusetts Institute of Technology Methods and compositions for overcoming immunosuppression
BR112021014592A2 (pt) 2019-01-25 2021-10-05 Suncor Energy Inc. Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas
CN109851770A (zh) * 2019-01-29 2019-06-07 天津大学 一种双端氨基的聚乙二醇的制备方法
IL285384B2 (en) 2019-02-13 2024-11-01 Alpheus Medical Inc Non-invasive sonodynamic therapy
AU2020222515B2 (en) 2019-02-15 2025-10-09 Nutrien Ag Solutions (Canada) Inc. The use of protoporphyrin IX derivatives to improve the health of plants
US11369280B2 (en) 2019-03-01 2022-06-28 California Institute Of Technology Velocity-matched ultrasonic tagging in photoacoustic flowgraphy
US12534714B2 (en) 2019-03-18 2026-01-27 The Broad Institute, Inc. Type VII CRISPR proteins and systems
US20220195514A1 (en) 2019-03-29 2022-06-23 The Broad Institute, Inc. Construct for continuous monitoring of live cells
CA3135291A1 (en) * 2019-03-29 2020-10-08 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy
WO2020206036A1 (en) 2019-04-01 2020-10-08 The Broad Institute, Inc. Novel nucleic acid modifier
US20220175848A1 (en) 2019-04-01 2022-06-09 The Broad Institute, Inc. Methods and compositions for cell therapy
WO2020236972A2 (en) 2019-05-20 2020-11-26 The Broad Institute, Inc. Non-class i multi-component nucleic acid targeting systems
US20220235340A1 (en) 2019-05-20 2022-07-28 The Broad Institute, Inc. Novel crispr-cas systems and uses thereof
MX2021014512A (es) 2019-05-29 2022-02-11 Sonalasense Inc Sonosensibilizacion.
US20220243178A1 (en) 2019-05-31 2022-08-04 The Broad Institute, Inc. Methods for treating metabolic disorders by targeting adcy5
GB201909692D0 (en) 2019-07-05 2019-08-21 Innovation Ulster Ltd Sonodynamic therapy
WO2021041922A1 (en) 2019-08-30 2021-03-04 The Broad Institute, Inc. Crispr-associated mu transposase systems
US12297426B2 (en) 2019-10-01 2025-05-13 The Broad Institute, Inc. DNA damage response signature guided rational design of CRISPR-based systems and therapies
US11981922B2 (en) 2019-10-03 2024-05-14 Dana-Farber Cancer Institute, Inc. Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
US11986269B2 (en) 2019-11-05 2024-05-21 California Institute Of Technology Spatiotemporal antialiasing in photoacoustic computed tomography
US12165747B2 (en) 2020-01-23 2024-12-10 The Broad Institute, Inc. Molecular spatial mapping of metastatic tumor microenvironment
WO2022032283A2 (en) 2020-08-07 2022-02-10 Alpheus Medical, Inc. Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
KR102578025B1 (ko) * 2020-12-07 2023-09-15 (주)아이엠지티 초음파 감작제가 결합된 면역관문억제제 및 이의 용도
US11813330B2 (en) 2021-03-04 2023-11-14 Theralase Technologies, Inc. Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents
CN113181060B (zh) * 2021-04-21 2022-05-13 武汉大学 一种具有除菌效果的复合纳米材料及其制备方法和应用
KR102742323B1 (ko) * 2021-07-15 2024-12-11 인천대학교 산학협력단 초음파 감작제가 탑재된 종양 표적화 엑소좀 및 이의 제조방법
US12504363B2 (en) 2021-08-17 2025-12-23 California Institute Of Technology Three-dimensional contoured scanning photoacoustic imaging and virtual staining
CN116161704A (zh) * 2023-02-14 2023-05-26 苏州大学 一种掺杂型镁铁水滑石及其制备方法与应用
US12593986B2 (en) 2023-04-12 2026-04-07 California Institute Of Technology Transmission mode-photoacoustic tomography of the human brain through an acoustic window
WO2025117544A1 (en) 2023-11-29 2025-06-05 The Broad Institute, Inc. Engineered omega guide molecule and iscb compositions, systems, and methods of use thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207405A (en) * 1977-09-22 1980-06-10 The B. F. Goodrich Company Water-soluble phosphorus containing carboxylic polymers
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5040537A (en) * 1987-11-24 1991-08-20 Hitachi, Ltd. Method and apparatus for the measurement and medical treatment using an ultrasonic wave
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5016615A (en) * 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
JPH0454132A (ja) * 1990-06-20 1992-02-21 Hitachi Ltd 波動による腫瘍治療用生理作用増強剤及びその製法
EP0610441A4 (de) * 1991-10-29 1996-01-10 Clover Cons Ltd Vernetzbare polysacchariden, polykationen und lipiden verwendbar zum einkapseln und abgabe von arzneimitteln.
US5321357A (en) * 1992-08-07 1994-06-14 Yale University Three-dimensional detection, dosimetry and imaging of an energy field by formation of a polymer in a gel
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US6159445A (en) * 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
AU1081097A (en) * 1995-11-24 1997-06-11 Ekos Corporation Hemostasis material and apparatus
US5840276A (en) * 1996-01-11 1998-11-24 Apfel Enterprises, Inc. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis
AU717193B2 (en) * 1996-03-26 2000-03-23 Pharmacyclics, Inc. Use of a texaphyrin in photodynamic therapy of pigment-related lesions
WO1998001131A1 (en) * 1996-07-05 1998-01-15 Hitachi, Ltd. Drugs inducing ultrasonic action and apparatus wherein the drugs are used
WO1998018497A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents
US5919135A (en) * 1997-02-28 1999-07-06 Lemelson; Jerome System and method for treating cellular disorders in a living being
US5817048A (en) * 1997-03-20 1998-10-06 Brown University Research Foundation Ultrasonic alternative to laser-based photodynamic therapy
IL120891A0 (en) * 1997-05-22 1997-09-30 Technion Res & Dev Foundation Photodynamic and sonodynamic therapy and agents for use therefor
GB9712525D0 (en) * 1997-06-16 1997-08-20 Nycomed Imaging As Method
US6233481B1 (en) * 1997-10-09 2001-05-15 Spectra Science Corporation Diagnostic application of sono-chemical excitation of fluorescent photosensitizers
US6071944A (en) * 1997-11-12 2000-06-06 Bowling Green State University Method of treatment of pigmented cancer cells utilizing photodynamic therapy

Also Published As

Publication number Publication date
US6498945B1 (en) 2002-12-24
WO1998052609A1 (en) 1998-11-26
EP0979104B1 (de) 2004-09-15
AU7443898A (en) 1998-12-11
GB9710049D0 (en) 1997-07-09
DE69826263T2 (de) 2005-10-27
JP2001525845A (ja) 2001-12-11
JP4503103B2 (ja) 2010-07-14
EP0979104A1 (de) 2000-02-16
DE69826263D1 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
ATE275971T1 (de) Sonodynamische therapie mit ultraschalsensibilisator
BR0016402A (pt) Método para aumentar a permeabilidade da pele ou do tecido mucoso a agentes farmaceuticamente ou cosmeticamente ativos administrados por via tópica ou transdérmica
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
TR200200327T2 (tr) Ağrı tedavisi için ürünler.
NO993393D0 (no) Fotokjemoterapeutiske blandinger
IL182352A (en) Use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
NO925038D0 (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
Fisher et al. A comparison of continuous ultrasound and pulsed ultrasound on soft tissue injury markers in the rat
DK0559145T3 (da) Lægemiddel til truende abort
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
DK1077683T3 (da) Antidepressiv behandling
US4476115A (en) Analgesic composition and method of treating subdermal pain
GEP20043231B (en) Resorcinol Composition
RU94028204A (ru) Препарат "уберсан" для лечения мастита у сельскохозяйственных животных
RU94000695A (ru) Средство с противоаллергическим действием
RU95107140A (ru) Способ лечения генерализованной формы демодекоза собак, осложненной стафилококкозом и грибковой инфекцией
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
DE69724228D1 (de) Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties